What is the recommended dosage for Mucinex (Guaifenesin and Dextromethorphan) Fast Max DM 5mg-100?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mucinex Fast Max DM Dosing Guide

For adults and children 12 years and older, the recommended dose is 10 mL every 12 hours, not exceeding 20 mL in 24 hours. 1

Age-Based Dosing

The FDA-approved dosing for dextromethorphan-containing products (which includes Mucinex Fast Max DM) is stratified by age:

  • Adults and children ≥12 years: 10 mL every 12 hours (maximum 20 mL per 24 hours) 1
  • Children 6 to under 12 years: 5 mL every 12 hours (maximum 10 mL per 24 hours) 1
  • Children 4 to under 6 years: 2.5 mL every 12 hours (maximum 5 mL per 24 hours) 1
  • Children under 4 years: Do not use 1

Administration Instructions

  • Shake the bottle well before each use 1
  • Use only the dosing cup provided with the product - do not substitute with other measuring devices 1
  • Do not use the provided dosing cup with other products to avoid dosing errors 1

Important Safety Considerations

Abuse potential: Dextromethorphan is subject to abuse, particularly among adolescents who may take megadoses (5-10 times the recommended dose) to achieve intoxicating effects similar to phencyclidine (PCP) 2. The drug is easily accessible over-the-counter, making it a target for misuse 2.

Genetic variability: Approximately 5% of individuals of European ethnicity lack the ability to metabolize dextromethorphan normally, which can lead to rapid accumulation of toxic levels even at recommended doses 2.

Combination product toxicity: Mucinex Fast Max DM contains both dextromethorphan and guaifenesin, and overdose toxicity is additive when multiple active ingredients are present 2.

Clinical Context

The guaifenesin component (expectorant) has a well-established safety profile in adults and pediatric populations, with typical dosing ranges of 200-400 mg every 4 hours (up to 6 times daily for immediate-release formulations) 3. Extended-release formulations like this product provide convenience with 12-hourly dosing 3. The most common adverse events with guaifenesin are mild gastrointestinal and nervous system effects 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.